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Using human skin explants, we investigated the effects of two different sunscreen preparations containing a
chemical UVB ﬁlter alone [sun protection factor (SPF) 5.2] or UVAþUVB ﬁlter [SPF 6.2] on sunburn cell formation,
dendritic cell (DC) migration, CD86- and CD1a-positive cell number, and tumor necrosis factor alpha (TNFa) and
interleukin (IL)-1, IL-10, and IL-12 production in the skin after irradiation with different doses of solar-simulated UV
radiation. Sunscreen- or placebo-treated skin explants were irradiated with solar-simulated UV radiation at 0.5, 1,
and 2 minimal erythematous dose equivalents (MEDE) (as determined in an in vivo human study) multiplied by the
SPF of the placebo or sunscreens. After irradiation, skin explants were ﬂoated on RMPI medium for 48 h. Cells that
had emigrated and the skin explants were histologically analyzed, and the soluble mediators were measured in
the supernatants by ELISA. Exposure to UV radiation led to concentration-dependent increases in sunburn cell
formation and TNFa production but a concentration-dependent decrease in DC migration and CD86- and CD1a-
positive cell number in the epidermis. Both chemical sunscreens protected against those alterations. The
immunoprotective capacity of the sunscreens correlated with their SPF but was independent of the sunscreens’
UVA protection capacity, suggesting that UVA is not a major factor for immunosuppression under the conditions
used in the model. UV irradiation did not significantly affect the vitality of emigrated DC; the expression of HLA,
CD80, and lag on emigrated cells; the number of CD1a-positive cells in the dermis; or the production of IL-1, IL-10,
and IL-12. We conclude that our model may be useful in determining the immunoprotective capacity of sunscreens.
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The suppressive effect of UV radiation on the human im-
mune system has been widely investigated over the last two
decades (Kripke, 1994; Duthie et al, 1999; Meunier, 1999;
Nghiem et al, 2002). UV radiation cause local immunosup-
pression mainly by a functional inhibition of Langerhans
cells and systemic immunosuppression in which cytokines,
including interleukin (IL)-10, seem to play an important role
(Schwarz and Schwarz, 2002). The increased risk of ther-
apeutically immunosuppressed organ transplant recipients
to develop non-melanoma skin cancers and melanoma on
sun-exposed sites highlights the importance of immuno-
suppressive effects (Jensen et al, 1999; Lindelof et al, 2000).
Indeed, UV radiation-mediated immunosuppression is
thought to be one of the most important factors for the
development of skin cancers (Kripke, 1994). For instance,
exposure to suberythemal doses (0.25 or 0.5 MED) of UV
radiation are sufficient to reduce the contact hypersensitiv-
ity response to a contact allergen by up to 50%–80% in
subjects with skin phototype I/II (Kelly et al, 2000), a form of
immunosuppression that has a relationship to skin cancer
susceptibility (Yoshikawa et al, 1990).
It is now known that sunscreens not only strongly protect
humans against sunburn but also can prevent the formation
of actinic keratoses (Thompson et al, 1993; Naylor et al,
1995; Green et al, 1999) and possibly squamous cell car-
cinoma (Green et al, 1999) in humans. The extent to which
sunscreens protect against UV-induced immunologic alter-
ations is controversial, however, and there is still no ac-
cepted method of establishing the correlation between a
sunscreen’s conventional sun protection factor (SPF) and
its immune protection factor (IPF) (Wolf and Kripke, 1997;
Gil and Kim, 2000; Baron and Stevens, 2003).
In vivo studies of sunscreen-based immunoprotection in
humans have been both rare and conflicting. In some of
these studies, sunscreens have been found to provide little
or no protection against UV-induced alterations of cuta-
neous immune response (Hersey et al, 1987; Van Praag
et al, 1991); in others, they have been found to completely
prevent UV-induced immunosuppression (Whitmore and
Morison, 1995; Serre et al, 1997). A number of other studies
have established that sunscreens exert an intermediate
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immunoprotection effect (Damian et al, 1997; Hayag et al,
1997; Moyal et al, 1997; Hochberg and Enk, 1999). The
conflicting results of these studies may be due to technical
aspects, including the spectra of light sources used and the
correct application of the sunscreens. Recently, it was found
that the UVA absorption properties of a sunscreen may be
one important factor determining its immunoprotective ca-
pacity (Kelly et al, 2003; Poon et al, 2003). The determination
of IPF in humans (at least using the standard local contact
allergy model) requires high numbers of subjects (Damian
et al, 1999; Kelly et al, 2003; Wolf et al, 2003) and, therefore,
is not easy possible in routine sunscreen testing.
Davenport et al (1997) have developed and tested an in
vitro model for gauging a sunscreen’s immunoprotective
effect by measuring the mixed epidermal cell lymphocyte
reaction (MECLR) of epidermal cells that have been cultured
from full-thickness skin, treated with sunscreen or placebo,
and irradiated. They found that all the test sunscreens pro-
tected beyond their designated SPF, whereas the sunscreen
vehicle conferred no protection. The work of Davenport et al
has resulted in much discussion and controversy (Chu et al,
1998; Gasparro, 1998; Wolf and Kripke, 1998; Fourtanier,
1999). For instance, the model of Davenport et al can only
assess one particular component of the skin’s immune re-
sponse at a time. Young and Walker (1998) criticized that
this model was not appropriate to test the IPF of sunscreens
as it required doses of 3–12 MED equivalents to suppress
MECLR. Furthermore, Davenport’s model does not meas-
ure other important components of the immune reaction
such as the migratory ability of dendritic cells (DC), which is
crucial for their immunologic potential or the production of
soluble immunomodulating factors such as tumor necrosis
factor alpha (TNFa) and IL-10. Interestingly, Pe´guet-Navarro
et al (2000), using a similar model than Davenport et al
(1997) but an UVB light source (instead of a solar simulator),
have calculated IPF, being consistent with the conventional
SPF of several sunscreens examined.
We recently examined the immunoprotective capacity of
two sunscreen preparations in a in vivo study in humans
using the standard model of UV-induced local suppression
of contact allergy to dinitrochlorobenzene (Wolf et al, 2003)
and, thus, we took the opportunity to investigate the
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Figure1
UV dose response and effects of
sunscreens on UV-induced changes
for the different endpoint parameters
in the skin explant model. The figure
shows the endpoint parameters for
which the statistical analysis revealed a
significant UV dose response in this
study, including (a) number of sunburn
cells per mm2 of skin explants irradiated
with different UV doses (po0.0001), (b)
concentration (pg per mL) of TNFa in the
medium used to culture skin explants
(po0.003), (c) CD1a-positive cells per
mm2 in the epidermis of skin explants
(po0.002), (d) number of emigrating
dendritic cells (DC) per cm2 of the skin
explant (po0.001), and (e) CD86-posi-
tive cells in percent of cells emigrated
out of skin explants (po0.0001) in rela-
tion to applied minimal erythema dose
equivalent (MEDE) multiplied by the SPF
of the UVB sunscreen (5.2) (gray bar),
UVAþB sunscreen (6.2) (dashed bar) or
placebo (1.05) (white bar). For graphic
purposes, the boxes of the box-and-
whiskers plots of some data were plot-
ted to reach from the first to the third
quartile and to intersect at the median.
The whiskers were plotted to reach from
the boxes out until 1.5 times the inter-
quartile range, though they were shrunk
to the outermost observation included.
Outliers shown from the whisker up to
1.5 times the interquartile range were
marked with circles. Extreme outliers
beyond this limit were marked with stars.
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immunoprotection of the very same sunscreens in an in vitro
model. We adapted an existing migration assay, first de-
scribed by Pope et al (1995) and modified by others (Rich-
ters et al, 1996; Kremer et al, 1997), for use in investigating
the protective effect of two sunscreen preparations against
UV-induced sunburn cell formation, changes in the number
of CD1a-positive cells in the epidermis and dermis, DC mi-
gration, expression of different markers for the activity of DC
on the migrated cells (CD80, CD86), and soluble immuno-
modulatory factor production (IL-1, IL-10, IL-12, TNFa) in ex
vivo skin. The ultimate goal of this study was to determine
whether this in vitro model may be useful as a screening
assay for the immunoprotective capacity of sunscreen
preparations.
Results
Dose effects of UV irradiation The effects of UV irradia-
tion at 0.5, 1, and 2 MEDE (minimal erythematous dose
equivalents) are shown in Fig 1. As revealed by examination
of hematoxylin- and eosin-stained specimens, there was
a UV concentration-dependent increase in the number of
sunburn cells in all treatment groups (po0.0001). Irradiation
at 1 MEDE increased the number sunburn cells in skin ex-
plants by approximately 70% (Fig 1a). Likewise, there was a
concentration-dependent increase in the amount of TNFa
(po0.003) in the ELISA analysis (Fig 1b). Moreover, there
were significant UV concentration-dependent decreases
in the number of CD1a-positive cells in the epidermis
(po0.002; Fig 1c), the total number of emigrant cells
(po0.007, data not shown), the number of emigrant DC
(po0.001; Fig 1d), and the amount of co-stimulatory mol-
ecule B7.2 (CD86) on emigrant cells (po0.0001; Fig 1e).
Finally, there was no concentration-dependent effect on the
vitality of emigrant cells; the expression of CD80, lag, or
HLA on emigrant cells; or the production of IL-1, IL-10, IL-12
in the skin explants (data not shown).
Effects of sunscreens Both sunscreens effectively pro-
tected against the UV-induced effects on all endpoint pa-
rameters examined, as evident from Fig 1. There were no
statistically significant differences in the effect of the UVB
sunscreen #321 and UVAþB sunscreen #322 on any pa-
rameter examined. For the immune endpoint parameters,
i.e., the number of CD1a-positive cells in the epidermis
(Fig 1c), the total number of emigrant cells, the number of
emigrant DC (Fig 1), and the amount of co-stimulatory mol-
ecule B7.2 (CD86) on emigrant cells (Fig 1e), the immuno-
protective capacity of the sunscreens correlated with their
SPF but was independent of the sunscreens’ UVA protec-
tion capacity, suggesting that UVA is not a major factor for
immunosuppression under the conditions used in the mod-
el. This is evident from the data in Fig 1 showing that the
values for the respective immune endpoint parameter were
in the same range, irrespective of the treatment with sun-
screen or placebo. After irradiation with 2 MEDE  SPF,
however, both sunscreens reduced the production of
TNFa by approximately 40% when compared with the
placebo (Fig 1b). In the same way, after irradiation with
2 MEDE  SPF, the sunscreens more strongly inhibited the
formation of sunburn cells than did the placebo (Fig 1a).
Discussion
In a placebo-controlled experimental in vitro study using
human skin explants, we investigated how well two sun-
screen preparations containing chemical UV filters could
protect the skin from damage caused by single exposures
to solar-simulated radiation at different doses. In particular,
a variety of endpoint parameters (including the number of
CD1a-positive cells in the epidermis, the total number of
emigrant cells, the number of emigrant DC, and the amount
of co-stimulatory molecule CD86-B7.2 on emigrant cells)
were examined to establish the immunoprotective capacity
of the sunscreens. Importantly, the in vitro immunoprotec-
tive capacity of the two sunscreen preparations correlated
with the in vivo IPF values, which had been previously es-
tablished in a study in human volunteers with the model of
UV-induced local suppression of the induction of contact
hypersensitivity (CHS) to dinitrochlorobenzene (Wolf et al,
2003).
UV irradiation resulted in significant concentration-de-
pendent reductions of CD1a-positive cells in the epidermis
in situ and emigrating DC and in our study. These findings
are not surprising considering the well known fact that UV
irradiation alters the number and morphology of human La-
ngerhans cells (Aberer et al, 1981) and the demonstration by
Stoitzner et al (2002) that DC migration is a highly active
process. The finding on UV-induced reduction of CD1a-
positive cells in the epidermis is consistent with the fact that
UV irradiation seems to alter and even destroy Langerhans
cells. Indeed, it is in good accordance with the results of
Richters et al (1996) and Kremer et al (1997), who both
found in similar in vitro models that the number of emigrat-
ing Langerhans cells decreased after irradiation with a sin-
gle dose of UVB. In vivo studies, however, have produced
conflicting results. On the one hand, Dandie et al (1980)
demonstrated in a sheep model a concentration-dependent
increase of Langerhans cells in the lymphatic vessels drain-
ing an area of UV-irradiated skin. On the other hand, in an
in vivo study in humans, Yawalkar et al (1998) demonstrated
the delayed enhancement of lymph flow after the irradiation
of a leg with 1 MED in the lymphatic vessels, but no in-
crease in Langerhans cells.
Irradiation also led to the lower expression of co-stimula-
tory molecule B7.2 on emigrant cells but left HLA ex-
pression unaltered. In addition, most CD86-negative cells
showed the typical DC morphology. The significance of this
finding is debatable. The expression of co-stimulatory mol-
ecule B7.2 is crucial for the antigen-presenting function of
Langerhans cells. Indeed, others have shown that irradia-
tion in vivo and vitro can downregulate B7.2 expression,
resulting in an impaired MECLR (Weiss et al, 1995; Dittmar
et al, 1999). In contrast, Kremer et al (1997) found that the
allostimulatory capacity of emigrant HLA-DR-positive cells
on human epidermal sheets was not impaired after UVB
irradiation.
We found that the formation of sunburn cells, a hallmark
of UV-induced skin damage (Kulms and Schwarz, 2000),
was UV-concentration-dependent in this study. Interesting-
ly, the extent of sunburn cell formation in our system was
greater than reported in previous in vivo studies, though this
difference may be due to the lack of blood circulation and
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inflammatory reaction in our model. We also observed a
concentration-dependent increase in TNFa production in
our model. This is an important finding since TNFa is es-
sential for the formation of sunburn cells (Schwarz et al,
1995) and mobilization of Langerhans cells. A similar in-
crease in TNFa production after irradiation was also seen in
several in vivo studies in humans. Wolf et al (2000) found an
upregulation of TNFa mRNA in biopsies of human epidermis
taken 6 h after irradiation with 2 MED in vivo. Barr et al
(1999) demonstrated an 8-fold increase in TNFa in suction
blisters after solar-simulated radiation with 3 MED. Skov
et al (1997) also detected a rapid increase in TNFa in the
fluid of suction blisters taken from volunteers after irradia-
tion with 3 MED of UVB.
The observed sunscreen protection against the produc-
tion of high TNFa levels may contribute to the lower number
of sunburn cells in the skin explants treated with sun-
screens. Importantly however, the sunscreen protection
against UV-induced sunburn cell formation and TNFa pro-
duction was greater than to be expected in light of the SPF
values of the sunscreens. Interestingly, this greater effect of
the sunscreen preparations on TNFa values we observed
was not reflected in either a smaller decrease in the number
of CD1a-positive cells in the skin explants or by a smaller
decrease in the number of emigrant cells. This is somehow
in contrast to the observed reduction of Langerhans cells
by epidermal treatment with TNFa in mice (Vermeer and
Streilein, 1990) and in humans (Cumberbatch et al, 1999).
Ludewig et al (1995), however, demonstrated that sponta-
neous apoptosis of Langerhans cells is partly mediated by
TNFa. In this context, it has to be stressed that the effects of
UV irradiation on the functional activity and morphology of
Langerhans cells in different species and even in different
mouse strains are highly variable (Vermeer and Streilein,
1990; Goetsch et al, 1998). Taken together, however, these
findings clearly indicate that measurement of sunburn cell
formation and/or TNFa formation is not a perfect indicator
for the conventional SPF and in particular for the in vivo
human IPF of a sunscreen, at least in our model.
Together, our results corroborate other in vitro studies
using human tissue that have shown a good immunopro-
tective effect of sunscreens. Davenport et al (1997) found
that several sunscreens inhibited the UVR-induced reduc-
tion of MECLR but a re-evaluation of the data showed that
the IPF of the sunscreens was lower than the SPF (Gas-
parro, 1998). In contrast, Pe´guet-Navarro et al (2000), who
used skin explants and UVB irradiation alone to test differ-
ent sunscreens, found that the SPF corresponded the IPF.
Using cis-UCA formation after UVB irradiation as a measure
of sunscreen efficacy in vivo and in vitro, van der Molen et al
(2000) were able to correlate cis-UCA formation with ME-
CLR data, prove that broad spectrum sunscreens were very
immunoprotective, and establish their in vitro method as
a potentially suitable test for immunoprotective efficacy.
Our in vitro findings show that both single agent and
broad spectrum sunscreens with low-moderate SPF have
immunoprotective effects consistent with their SPF and IPF
levels, as determined in an in vivo study in human volun-
teers (Wolf et al, 2003). Whether this is also the case for
sunscreens with high SPF remains to be investigated. The
observation that the immunoprotective capacity of the sun-
screens in our model was independent of the UVA protec-
tion capacity suggests that it is consistent with the results
of our in vivo study that UVB is much more important than
UVA in causing immunosuppression. Some caveats aside
(e.g., great interindividual differences of skin examples and
technical limitations attendant on accessing large samples
of skin), we conclude that our in vitro model is useful and
valid in determining the immunoprotective capacity of sun-
screens.
Materials and Methods
Chemical sunscreens and placebo This study was one part of
a multicenter project supported by the European Community
and proprietary sunscreen preparations were kindly provided by
Beiersdorf AG (Hamburg, Germany). A preparation designated
as UVB sunscreen #321 contained 4% of the chemical UVB
filter methylbenzylidine camphor, and a preparation designated
as broad-spectrum UVAþB sunscreen #322 contained 4%
methylbenzylidine camphor and 1.5% butyl methoxy dibenzoyl-
methane, a chemical UVA filter (Wolf et al, 2003). The same oil-
in-water emulsion (containing stearic acid, glyceryl stearate,
octyldodecanol, dicaprylyl ether, cetearyl alcohol, phenoxyethanol,
methylparaben, ethylparaben, propylparaben, butylparaben, sodi-
um hydroxide, glycerin, trisodium EDTA, caprylic/capric triglycer-
ide, and carbomer) was used as vehicle for formulation of both
sunscreens. The absorbance spectra of the sunscreens have been
previously reported (Wolf et al, 2003).
The conventional SPF of each sunscreen and the placebo
preparation had been determined previously by us in a separate
clinical study (Wolf et al, 2003), in accordance with US Food and
Drug Administration (FDA) guidelines. The values were as follows:
UVB sunscreen #321, SPF 5.2; UVAþB sunscreen #322, SPF 6.2;
placebo, SPF 1.05.
Human skin explants and the sunscreen application Human
split skin samples (0.3–0.5 mm thick) were obtained from each of
12 individuals undergoing plastic surgery at our institution (6 men,
6 women; median age, 66.5 y, range, 40–89 y; skin type II [n¼ 3] or
III [n¼ 9]). In all cases, patients had given informed consent before
skin excision. The skin samples were removed from the thigh using
a dermatome. The whole skin explants measured at least 5  10
cm. After excision, each split skin sample was divided into 2 equal
pieces and kept in Petri dishes containing phosphate-buffered sa-
line (PBS). The epidermal side of the samples were set at the air–
liquid interphase in the petri dishes. One half was treated with
placebo and the other with sunscreen (either UVB sunscreen #321
or UVAþB sunscreen #322), each evenly applied at a concentra-
tion of 2 mg per cm2 (checked by weighing of the applied sunscreen
amount) on the epidermal side of the skin explant 20 min before UV
irradiation. Immediately before UV exposure, each of the two piec-
es of split skin was divided into four equal parts and put into a Petri
dish with 1.5 mL (PBS). For each sunscreen, 6 different skin ex-
plants were used to study the effect of UV exposure (Fig 2).
UV radiation source UV radiation was provided by an Oriel 1000
W solar simulator (Oriel, Darmstadt, Germany) equipped with a
dichroic mirror, an atmospheric attenuation filter (Oriel No. 81017,
WG320/1 mm), and a UG5/1 mm (Oriel No. 81019) visible infrared
light bandpass blocking filter, as previously described and used in
the clinical study for SPF sunscreen testing (Wolf et al, 2003). Ir-
radiance was routinely measured and monitored by a wide-band
thermopile radiometer (Dexter Research 2 M model with quartz
window) (Medical Physics, Dryburn Hospital, Durham, UK), cali-
brated by the Regional Medical Physics Department, Royal Victoria
Infirmary Unit (Newcastle-upon-Tyne, UK), using a reference ther-
mopile (Hilgar-Swartz FT17). The total irradiance at 20 cm from the
lens was 12.0 mW per cm2, as measured by the wide-band Dexter
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Research thermopile radiometer. During the study, this UV irradi-
ance of the Oriel solar simulator was kept constant by use of an
integrated automated photo feedback system. The spectrum of the
light source conformed to FDA (Food and Drug Administration,
1999) and COLIPA (1994) regulations for sunscreen testing, as de-
termined by an International Light spectroradiometer system (In-
ternational Light, Newburyport, Massachusetts).
UV irradiation of skin explants UV irradiation of the skin explants
was performed using multiples of a mean MEDE that had been
previously determined in vivo in 88 volunteers, using the same Oriel
1000 W solar simulator than used in the present study (Wolf et al,
2003). The MEDE was produced by a mean UV dose of 5748 mJ
per cm2, which was obtained after a mean irradiation time of 479 s
using the Oriel solar simulator. The distance between the outer-
most filter of the solar simulator and each skin explant was 20 cm
during UV irradiation. Sunscreen- and placebo-treated skin ex-
plants were irradiated at the same time in the same irradiation field
of the solar simulator. Controls were sham irradiated. Sunscreen-
treated skin explants received 0.5, 1, and 2 MEDEs multiplied by
the SPF of each sunscreen (UVB sunscreen #321, SPF 5.2;
UVAþB sunscreen, SPF 6.2). The placebo-treated skin equiva-
lents received 0.5, 1, and 2 MEDEs multiplied by the SPF of the
placebo (1.05). After irradiation, at least 3 punch biopsy specimens
(each 6 mm in diameter) were taken from each skin explant and
floated, epidermal side up, in 1.5 mL of medium (RMPI 1640 (PAA
Laboratories, catalog no. E15-039) supplemented with 10% fetal
bovine serum and 2% penicillin, streptomycin, and glutamine) in
12-well plates (Costar 3512 Corning B.V. Life Science, Shipol-Rijk,
The Netherlands). After 48 h, the biopsy specimens were removed
and divided for histological and immunohistochemical processing.
One half of each punch biopsy was fixed in formalin and the other
half was cryopreserved.
Evaluation of dendritic cell migration The medium containing
non-adherent cells that had emigrated from the skin by 48 h was
collected. The cells were spooned down, and the remaining me-
dium was stored at 201C for analysis of soluble factors. The cells
that had been removed from the medium were then washed in
PBS, spooned down again, and resuspended in 100 mL PBS. The
emigrant cells were stained with trypan blue and stained and un-
stained cells were counted in a Neubauer chamber to determine
the vitality. DC were distinguished by the typical morphology from
other leucocytes.
For immunohistochemical analysis and identification of dendri-
tic cells (DC), 20 mL of the cell suspension was pipetted onto one
field of adhesion slides (Bio-Rad Laboratories GmbH, Mu¨nchen,
Germany), fixed, and stained with the antibodies lag (kindly pro-
vided by D. Strunk, Department of Hematology, University of Graz,
Graz, Austria), HLA-DR (Becton Dickinson and Company, Franklin
Lakes, New Jersey), CD-80 (Biodesign International, Saco, Maine),
and CD-86 (Serotec GmbH, Du¨sseldorf, Germany), using the
APAAP technique. All specific antibodies had the IgG1 isotype and
were used at a dilution of 1:10. IgG1 antibody (Becton Dickinson
and Company) staining served as negative control. Automated
counting of cells on the adhesion slides was performed using a KS
400 3.0 image analysis system (Zeiss Vision, Hallbergmoos, Ger-
many). For this purpose, an Axioskop bright-field microscope was
mounted on a scanning table (Zeiss Vision) with a three-chip digital
color video camera (Sony, Tokyo, Japan). A  20 objective was
used, yielding a final magnification of 0.66 mm per pixel. Illumina-
tion was kept constant at a mean gray value of 200þ 4 in a white
field. Each image was automatically focused, enhanced by additive
shading correction, and contrast-enhanced by gray level rescaling
and delineate filtering. For automated counting of positive and
negative cells, each well of the adhesion slides was scanned with
an appropriate meander consisting of 41 fields of 512  512 pixels
and a measurement frame of 450  540 pixels, and each cell was
classified according to the learning set by multivariate linear dis-
criminant analysis as implemented in the KS 400 3.0 program
package. The numbers of all cells and of immunohistologically
positive cells in each well were recorded, and the percentage of
positive cells was calculated.
Evaluation of sunburn cell formation Sunburn cells in skin sam-
ples mounted on hematoxylin- and eosin-stained slides were
counted using the same image analysis approach and the same
magnification as described above for DC. First, each whole section
was automatically scanned, and the area of the epidermis without
the stratum corneum was interactively measured in each high-
power field. Second, the sunburn cells were marked interactively.
Finally, the number of sunburn cells per mm2 epidermis was
calculated.
Evaluation of CD1a-positive cells in the skin explants Four-
micrometer-thick cryostat sections of each skin explant were
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Figure 2
Experimental setup of the treatment and UV irradiation protocol. An identical setup was used for both the UVB sunscreen #321 and the UVAþB
sunscreen #322. SPF #321, 5.2; SPF #322, 6.2; SPF placebo, 1.05.
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automatically stained with CD1a mouse monoclonal antibody (di-
lution 1:50, Immunotech, Marseille, France) using a TechMate Ho-
rizon automated stainer and the DAKO ChemMate peroxidase/
AEC rabbit/mouse detection kit K 5005 (DAKO, Cytomation,
Glostrup, Denmark). Sections were counterstained with hem-
atoxylin. Positive cells were counted in the same manner as were
the sunburn cells. In addition, the dermal area of the sections was
interactively measured and the positive dermal cells marked.
Soluble immunomodulatory factor analysis Commercial ELISA
kits (R&D Systems, Minneapolis, Minnesota) were used to measure
IL-1 (minimal detectable concentration: 1 pg per mL) and IL-12
(minimal detectable concentration: 5 pg per mL) levels in the me-
dium. ‘‘High-sensitivity’’ assay systems (R&D Systems) were used,
according to the manufacturers’ protocols, to measure TNFa
(minimal detectable concentration: 0.5 pg per mL) and interleukin
10 levels (minimal detectable concentration: 0.5 pg per mL).
Statistical analysis The 12 skin explants constituted independent
experimental units. The factors UV radiation (4 levels) and treat-
ment (placebo and sunscreens) were varied within each skin ex-
plant, resulting in eight repeated measures. The treatments (two
different types of sunscreens) varied between skin explants. All
measurements of an outcome measure were rank transformed in
order to make the analysis robust against non-symmetric distribu-
tions and outliers. Linear contrasts were calculated by multiplying
each measurement with a coefficient and summing-up the prod-
ucts for each skin explant. By this approach, the number of meas-
urements were reduced to one per explant (Armiatage and Berry,
1987, p 201; Altmann, 1991, p 426ff). Statistical tests on the con-
trasts assumed that they were independently and normally dis-
tributed. The first contrast corresponded to the slope of a linear
dose–response relation between UV radiation and outcome meas-
urement. The measurements were multiplied with the difference
between dose and mean dose and summed-up per explant. The
doses used were MEDE divided by the SPF. Under the null hy-
pothesis of no dose effect the mean contrast would have been
zero. This hypothesis was tested by the one-sample t test. The
contrast corresponding to the slope differences between treatment
and placebo within an explant was obtained by again multiplying
each measurement with the difference between dose and mean
dose, but for placebo treated patches it was multiplied by minus
one in addition. The difference between the sunscreen groups was
tested by a two-group t-test on the contrasts corresponding to
slope differences. The potential effect of different plates was not
investigated. Two-sided p-values less than 0.05 were considered
statistically significant.
DOI: 10.1111/j.0022-202X.2004.23322.x
Manuscript received August 16, 2002; revised April 25, 2004; accepted
for publication May 5, 2004
Address correspondence to: Rainer Hofmann-Wellenhof, Department
of Dermatology, University of Graz, Graz, Austria. Email: rainer.hofmann
@uni-graz.at
References
Aberer W, Schuler G, Stingl G, Ho¨nigsmann H, Wolff K: Ultraviolet light depletes
surface markers of Langerhans cells. J Invest Dermatol 76:202–210, 1981
Altmann DG: Practical statistics for medical research. London: Chapman and
Hall, 1991
Armiatage P, Berry G: Statistical methods in medical research. Oxford: Blackwell
Scientific Publications, 1987
Baron ED, Stevens SR: Sunscreens and immune protection. Br J Dermatol
146:933–937, 2003
Barr RM, Walker SL, Tsang W, et al: Suppressed alloantigen presentation, in-
creased TNF-alpha, IL-1, IL-1Ra, IL-10, and modulation of TNF-R in UV-
irradiated skin. J Invest Dermatol 112:692–698, 1999
Chu AC, Davenport V, Morris JF: Immunologic protection afforded by sun screens
(comment). J Invest Dermatol 111:340, 1998
COLIPA sun protection factor (SPF) test method. The European Cosmetic Toiletry
and Perfumery Association (COLIPA), October, Ref, 94/289, 1994
Cumberbatch M, Griffiths CEM, Tucker SC: Tumour necrosis factor-alpha induc-
es Langerhans cell migration in humans. Br J Dermatol 141:192–200,
1999
Damian DL, Barnetson RS, Halliday GM: Measurement of in vivo sunscreen im-
mune protection factors in humans. Photochem Photobiol 70:910–915,
1999
Damian DL, Halliday GM, Barnetson RS: Broad-spectrum sunscreens provide
greater protection against ultraviolet radiation-induced suppression of
contact hypersensitivity to a recall antigen in humans. J Invest Dermatol
109:146–151, 1997
Dandie GW, Clydesdale GJ, Jacobs I, Muller HK: Effects of UV on the migration
and function of epidermal antigen presenting cells. Mutat Res 422:
147–154, 1980
Davenport V, Morris JF, Chu AC: Immunologic protection afforded by sunscreens
in vitro. J Invest Dermatol 108:859–863, 1997
Dittmar HC, Weiss JM, Termeer CC, et al: In vivo UVA-1 and UVB irradiation
differentially perturbs the antigen-presenting function of human epidermal
Langerhans cells. J Invest Dermatol 112:322–325, 1999
Duthie MS, Kimber I, Norval M: The effects of ultraviolet radiation on the human
immune system. Br J Dermatol 140:995–1009, 1999
Food and Drug Administration Sunscreen products for over-the-counter human
use. Final Monograph FR, Federal Register. 64:27666–27693, 1999
Fourtanier A: In vitro determination of erythema and immunologic protection af-
forded by sunscreens do not accord with in vivo assessments. J Invest
Dermatol 112, 1999
Gasparro FP: Photobiology 101. J Invest Dermatol 110:183, 1998
Gil EM, Kim TH: UV-induced immue supression and sunscreen. Photoderm
Photoimmunol Photomed 16:101–110, 2000
Goetsch W, Hurks HMH, Garssen J, et al: Comparative immunotoxicology of
ultraviolet B exposure I. Effects of in vitro and in situ ultraviolet B expo-
sure on the functional activity and morphology of Langerhans cells in the
skin of different species. Br J Dermatol 139:230–238, 1998
Green A, Williams G, Neale R, et al: Daily sunscreen application and betacar-
otene supplementation in prevention of basal-cell and squamous-
cell carcinomas of the skin: A randomised controlled trial. Lancet 354:
723–729, 1999
Hayag MV, Chartier T, DeVoursney J, Tie C, Machler B, Taylor JR: A high SPF
sunscreen’s effects on UVB-induced immunosuppression of DNCB con-
tact hypersensitivity. J Dermatol Sci 16:31–37, 1997
Hersey P, MacDonald M, Burns C, Schibeci S, Matthews H, Wilkinson FJ: Anal-
ysis of the effect of a sunscreen agent on the suppression of the allo-
activating capacity in human skin in vivo. J Invest Dermatol 97:629–633,
1987
Hochberg M, Enk CD: Partial protection against epidermal IL-10 transcription and
Langerhans cell depletion by sunscreens after exposure human skin to
UVB. Photochem Photobiol 70:766–772, 1999
Jensen P, Hansen S, Moller B, et al: Skin cancer in kidney and heart transplant
recipients and different long-term immunosuppressive therapy regimens.
J Am Acad Dermatol 40:177–186, 1999
Kelly DA, Seed PT, Young AR, Walker SL: A commercial sunscreen’s protection
against ultraviolet radiation-induced immunosuppression is more than
50% lower than protection against sunburn in humans. J Invest Dermatol
120:65–71, 2003
Kelly DA, Young AR, McGregor JM, Seed PT, Potten CS, Walker SL: Sensitivity to
sunburn is associated with susceptibility to ultraviolet radiation-induced
suppression of cutaneous cell-mediated immunity. J Exp Med 191:
561–566, 2000
Kremer IB, Sylva-Steenland RS, Bos JD, Teunissen MBM: Despite the presence
of UVB-induced DNA damage HLA-Drþ cells from ex vivo UVB-exposed
human skin are able to migrate and show no impaired allostimulatory
capacity. J Invest Dermatol 109:626–631, 1997
Kripke ML: Ultraviolet radiation and immunology: Something new under the
sun—Presidential address. Cancer Res 54:6102–6105, 1994
Kripke ML: New measures of photoprotection. Exp Dermatol 11 (Suppl. 1):7–8,
2002
Kulms D, Schwarz T: Molecular mechanisms of UV-induced apoptosis. Photo-
dermatol Photoimmunol Photomed 16:195–201, 2000
Lindelof B, Sigurgeirsson B, Gabel H, Stern RS: Incidence of skin cancer in 5356
patients following organ transplantation. Br J Dermatol 143:513–519,
2000
786 HOFMANN-WELLENHOF ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Ludewig B, Graf D, Gelderblom HR, Becker Y, Kroczek RA, Pauli G: Spontaneous
apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand)
and TNF-alpha, but strongly enhanced by interleukin-10. Eur J Immunol
25:1943–1950, 1995
Meunier L: Ultraviolet light and dendritic cells. Eur J Dermatol 9:269–275, 1999
Moyal D, Courbie`re C, Le Corre Y, de Lacharrie`rre O, Hourseau C: Immunosup-
pression induced by chronic solar-simulated irradiation in humans and its
prevention by sunscreens. Eur J Dermatol 7:223–225, 1997
Naylor MF, Boyd A, Smith DW, Cameron GS, Hubbard D, Neldner KH: High sun
protection factor sunscreens in the suppression of actinic neoplasia. Arch
Dermatol 131:170–175, 1995
Nghiem DX, Kazimi N, Mitchell DL, et al: Mechanisms underlying the suppression
of established immune responses by ultraviolet radiation. J Invest
Dermatol 119:600–608, 2002
Pe´guet-Navarro J, Dalbiez-Gauthier C, Courtellemont P, Schmitt D: In vitro de-
termination of sunscreen immune protection factors. Arch Dermatol Res
292:306–311, 2000
Poon TSC, Barneston RS, Halliday GH: Prevention of immunosupression by
sunscreens in humans is unrelated to protection from erythema and de-
pendent on protection from ultraviolet A in the face of constant ultraviolet
B protection. J Invest Dermatol 121:184–190, 2003
Pope M, Betjes MGH, Hirmand H, Hoffman L, Steinman RM: Both dendritic cells
and memory T lymphocytes emigrate from organ culture of human skin
and form distinctive dendritic-T-cell conjungates. J Invest Dermatol
104:11–17, 1995
Richters CD, Reits EAJ, Van Pelt AM, et al: Effect of low dose UVB irradtiation on
the migratory properties and functional capacities of human skin dendritic
cells. Clin Exp Immunol 104:191–197, 1996
Schwarz A, Bhardwaj R, Aragane Y, et al: Ultraviolet-B-induced apoptosis of
keratinocytes: Evidence for partial involvement of tumor necrosis factor-
alpha in the formation of sunburn cells. J Inves Dermatol 104:922–927,
1995
Schwarz A, Schwarz T: Molecular determinants of UV-induced immunosuppres-
sion. Exp Dermatol 11 (Suppl. 1):9–12, 2002
Serre I, Cano JP, Picot MC, Meynadier J, Meunier L: Immunosuppression in-
duced by acute solar-simulated ultraviolet exposure in humans: Preven-
tion by a sunscreen with sun protection factor of 15 and high UVA
protection. J Am Acad Dermatol 37:187–194, 1997
Skov L, Hansen H, Allen M, et al: Contrasting effects of ultraviolet A1 and ul-
traviolet B exposure on the induction of tumor necrosis factor-alpha in
human skin. Br J Dermatol 138:216–220, 1997
Stoitzner P, Pfaller K, Stossel H, Romani N: A close-up view of migrating
Langerhans cells in the skin. J Invest Dermatol 118:117–125, 2002
Thompson SC, Jolley D, Marks R: Reduction of solar keratoses by regular sun-
screen use. N Engl J Med 329:1147–1151, 1993
van der Molen RG, Out-Luiting C, Driller H, Claas FHJ, Koerten HK, Mommaas
AM: Broad-spectrum sunscreens offer protection against urocanic acid
photoisomerization by artifical ultraviolet radiation in human skin. J Invest
Dermatol 115:421–426, 2000
Van Praag MCG, Out-Luiting C, Claas FHJ, Vermeer BJ, Mommaas AM: Effects
of topical sunscreens on the UV-radiation-induced suppression of the
alloactivating capacity in human skin in vivo. J Invest Dermatol 97:
629–633, 1991
Vermeer M, Streilein JW: Ultraviolet B light-induce alterations in epidermal
Langerhans cells are mediated in part by tumor necrosis factor-alpha.
Photodermatol Photoimmunol Photomed 7:258–265, 1990
Weiss JM, Renkl AC, Denfeld RW, et al: Low-dose UVB radiation perturbs the
functional expression of B7.1 and B7.2 co-stimulatory molecules on hu-
man Langerhans cells. Eur J Immunol 25:2858–2862, 1995
Whitmore SE, Morison WL: Prevention of UVB-induced immunosuppression
in humans by a high sun protection factor. Arch Dermatol Res 131:
1128–1133, 1995
Wolf P, Hoffmann Ch, Quehenberger F, Grinschgl S, Kerl H: Immune protection
factors of chemical sunscreens measured in the local contact hypersen-
sitivity model in humans. J Invest Dermatol 121:1080–1087, 2003
Wolf P, Kripke ML: Immune aspects of sunscreens. In: Gasparro F (ed). Sun-
screen Photobiology: Molecular, Cellular and Physiological Aspects. Ber-
lin: Springer, 1997; p 99–118
Wolf P, Kripke ML: Immunologic protection afforded by sunscreens beyond des-
ignated sun protection factor? (letter). J Invest Dermatol 110:184, 1998
Wolf P, Maier H, Mu¨llegger R, et al: Topical treatment with liposomes containing
T4 endonuclease V protects human skin in vivo from ultraviolet-induced
upregulation of interleukin-10 and tumor necrosis factor-alpha. J Invest
Dermatol 114:149–156, 2000
Yawalkar N, Aebischer MC, Hunger R, Brand CU, Braathen LR: Effects of UV
irradiation with one minimal erythema dose on human afferent skin lymph
in vivo. Exp Dermatol 7:362–368, 1998
Yoshikawa T, Rae V, Bruins-Slot W, Van den Berg JW, Taylor JR, Steilein JW:
Susceptibility of effects to UVB radiation of contact hypersensitiviy as a
risk factor for skin cancer in humans. J Invest Dermatol 95:530–536, 1990
Young A, Walker SL: Protection factors are ratios. J Invest Dermatol 111:912,
1998
SUNSCREEN IN VITRO IMMUNE PROTECTION 787123 : 4 OCTOBER 2004
